AI-assisted analgesia copilot to guide remifentanil dosing during general anesthesia
Official title: AI-assisted Analgesia Copilot System for Proper Management of Nociception
Run by Pontificia Universidad Catolica de Chile · NCT07253012 · Data updated 2026-11-12
This project will test an AI 'co-pilot' that monitors multiple physiological signals during general anesthesia to guide remifentanil dosing and reduce over- or under-dosing for adults having elective surgeries of 2–4 hours.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Pontificia Universidad Catolica de Chile Academic / other |
| Locations | 2 sites (Santiago and 1 other locations) |
| Status | Recruiting |
| Started | January 29, 2026 |
| Main results expected | October 27, 2026 |
| Study ends | October 27, 2027 |
| Registry record updated | March 9, 2026 |
| Trial ID | NCT07253012 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults scheduled for elective surgery under general anesthesia expected to last between two and four hours are the intended participants.
✕Probably not a fit
Patients undergoing emergency surgery, pregnant patients, those with pre-existing mental or intellectual disability, drug dependence, surgeries shorter than two hours or longer than four hours, or cases with major intraoperative complications are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project develops and applies a machine-learning/AI co-pilot that integrates data from hemodynamic monitors, BIS, TOF, ANI, anesthesia machines, and infusion pumps to monitor nociception in real time. The system aims to distinguish genuine nociceptive responses from confounding physiological signals and to support precise titration of remifentanil using target-controlled infusion. Data will be captured during elective general anesthesia cases lasting between two and four hours to train and validate the algorithm in a clinical operating-room environment. The intent is to create a clinical implementation tool that can provide actionable, real-time guidance for individualized opioid dosing.
Why it matters
Potential benefit: If successful, this could enable more precise remifentanil dosing during surgery, lowering opioid-related complications and improving recovery and cost-effectiveness.
How similar studies have gone: Prior work using nociception indices and PK/PD models has shown promise, but fully integrated AI co-pilot systems for intraoperative opioid titration remain largely unproven in routine clinical practice.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients scheduled for elective surgery with general anesthesia. * Surgeries scheduled to last at least two hours. Exclusion Criteria: * Patients undergoing emergency surgery. * Pregnant women. * Presence of a mental or intellectual disability before the hospitalization. * Drug dependence. * Surgeries scheduled for more than 4 hours. * Intraoperative complications requiring changes in routine behavior.
Where it's running
-
Hospital Clinico UC Christus
Santiago, Chile Recruiting -
Division de Anestesiologia
Santiago, Chile Not yet recruiting
Study contacts
- Principal investigator: Victor Contreras, RN, MSN — Pontificia Universidad Catolica de Chile
- Study coordinator: Victor Contreras, RN, MSN
- Email: vecontre@uc.cl
- Phone: +56955049217
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-assisted whole-course management for safe medicine use in advanced solid tumors
A real-world study compares a smartphone-based digital management system with usual care to see if it reduces drug-related problems and healthcare needs for adults with advanced solid tumors receiving cancer therapy.
-
AI-assisted and traditional workflows for admission diagnosis and management planning
This trial tests whether an AI-agent workflow helps doctors make better admission diagnoses and care plans on simulated cases, compared with plain AI-assisted and traditional workflows.
-
Prediction score for death or lung transplant in emphysema caused by alpha-1 antitrypsin deficiency
This study tests a new prediction tool to identify people with emphysema due to alpha-1-antitrypsin deficiency who are at high risk of death or needing a lung transplant.
-
Timing of AI Help in Chest X-Rays: Does When AI Becomes Visible Change How Clinicians Read Images?
Doctors test chest X-ray interpretation with AI information shown either before or after they start reviewing the image to see how timing affects their search patterns and decisions.
-
Does AI-based cephalometric tracing match digital manual tracing for orthodontic measurements?
This study tests whether AI-powered cephalometric analysis can produce measurements similar to traditional digital tracing in 100 patient radiographs.
-
Heart score calculator test using GPT-4o and Claude in chest pain patients
This study tests whether two large language models can calculate HEART scores from patient notes and predict 30-day adverse heart events in adults with chest pain in the emergency department.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.